{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2021"],"condition":["Colorectal adenoma"],"disease":["Colorectal Adenoma"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/35380"],"location":["China"],"study_start_month":["12"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Clinical evaluation of Canmei formula in the prevention and treatment of recurrence of intestinal adenoma after endoscopic resection","description":"Intervention group:Canmei formula;Control Group:Berberine hydrochloride\nPrimary outcome(s): Safety\nStudy Design: Case-Control study","dates":{"creation":"2021-12-15"},"accession":"35380","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2100054824"],"Chinese Medicine Clinical Trials Registry":["ChiMCTR2100005456"],"International Traditional Medicine Clinical Trial Registry":["ITMCTR2100005456"]}}